Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 1249 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
ORIGINAL ARTICLE
Year : 2017  |  Volume : 7  |  Issue : 3  |  Page : 160-164

Novel cardiovascular risk markers in Nigerian cigarette smokers


1 Department of Medical Biochemistry, College of Health Sciences, University of Ilorin, Ilorin, Nigeria
2 Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Nigeria
3 Department of Medicine, Division of Respiratory Medicine, University of Ilorin, Ilorin, Nigeria
4 Department of Chemical Pathology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria
5 Department of Family Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria

Correspondence Address:
Godwin O Adunmo
Department of Medical Biochemistry, College of Health Sciences, University of Ilorin, PMB 1515, Ilorin
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijabmr.IJABMR_140_16

Rights and Permissions

Background: Cardiovascular disease (CVD) is the leading cause of mortality and morbidity worldwide. While the effect of cigarette smoking on conventional markers that account for <50% of CVD s has been well studied, there are only a few studies on the effect of cigarette smoking on novel cardiovascular (CV) risk markers. Objective: To evaluate the effect of cigarette smoking on the novel CV markers such as homocysteine (HCY), lipoprotein (a) (Lp(a)), and C-reactive protein (CRP). Materials and Methods: One hundred and forty smokers, 12 ex-smokers, and 84 controls were recruited for the study. A structured questionnaire was used to obtain information on their clinical history, daily cigarette consumption, and duration of smoking. The smokers were further grouped according to the amount of cigarette consumption: light (<5 sticks/day), moderate (6–10 sticks/day), and heavy (>10 sticks/day) and duration of smoking: short (5–10 years), medium (11–20 years), and long (>20 years). HCY was determined by enzyme-linked immunosorbent assay method, and Lp(a) and CRP were determined spectrophotometrically. Results: HCY, Lp(a), and CRP were significantly elevated in smokers when compared with control (P < 0.05) and they correlated with daily cigarette consumption and duration of smoking. Ex-smokers also exhibited a significant increase in HCY, Lp(a), and CRP level (P < 0.05) when compared with the control, but were significantly lower than the current smokers. Conclusion: There is a linear relationship between the intensity and duration of cigarette smoking and serum levels of all three novel risk CV markers. These findings suggest that these markers may be an important mechanism by which smoking promotes atherosclerosis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed471    
    Printed6    
    Emailed0    
    PDF Downloaded127    
    Comments [Add]    

Recommend this journal